Szymon Juszkiewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Szymon Juszkiewicz has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro M. Chibly
Matrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA
18 shared publications - Anwesha Dey
Genentech
18 shared publications - Dexter X. Jin
Foundation Medicine, Inc., Boston, Massachusetts
18 shared publications - Ethan S. Sokol
Foundation Medicine , Cambridge, MA
18 shared publications - Eun Jung Kim
Translational Medicine Oncology, Genentech Inc., South San Francisco, California
18 shared publications - Jack Kamm
Computational Sciences Center of Excellence, Genentech Inc, South San Francisco, CA, USA
18 shared publications
Latest Publications
- 17 September 2026
- Published by Elsevier in Molecular Cell
- Vol. 86 (18) , 3803-3821.e17
Molecular mechanism of HUWE1-HAPSTR1-USP7-mediated ubiquitin chain amplification on nuclear proteins
- 17 September 2026
- Published by Elsevier in Molecular Cell
- Vol. 86 (18) , 3803-3821.e17
Molecular mechanism of HUWE1-HAPSTR1-USP7-mediated ubiquitin chain amplification on nuclear proteins
- Open Access
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Association analyses of aneuploidy score with AR, GID4, AKT3, FGF10, EWSR1, and POLD1
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Association analyses of aneuploidy score with AR, GID4, AKT3, FGF10, EWSR1, and POLD1
- Open Access
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Structural analysis of the exonuclease domain of POLE
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Structural analysis of the exonuclease domain of POLE
- Open Access
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Detailed characterization of TP53 alterations in breast cancer, colorectal cancer, NSCLC, ovarian cancer, pancreatic cancer and prostate cancer
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Detailed characterization of TP53 alterations in breast cancer, colorectal cancer, NSCLC, ovarian cancer, pancreatic cancer and prostate cancer
- Open Access
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Characterization of whole genome doubling status
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Characterization of whole genome doubling status
- Open Access
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Trinucleotide motif counts on human genome
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Trinucleotide motif counts on human genome
- Open Access
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Additional analyses of the all-in-one inducible adenine base editor
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Additional analyses of the all-in-one inducible adenine base editor
- Open Access
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Association analyses of aneuploidy score with TMB, mutational signatures, and microsatellite instability
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Association analyses of aneuploidy score with TMB, mutational signatures, and microsatellite instability
- Open Access
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
SgRNA counts from the base editor screening
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
SgRNA counts from the base editor screening
- Open Access
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Elastic net regression for TMB
- 2 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells
Elastic net regression for TMB